Lexaria Bioscience Corp. LEXX
Set alert
As of Nov 3, 2:53 PM ET
- YTD
- -56.80%
- 1 year
- -74.36%
- Open
- 3.79
- Prev close
- 3.64
- Mkt cap
- 8.43M
- Vol
- 19.65K
- Avg vol
- 74.60K
- EPS
- -5.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.79
- High
- 4.10
- Forward P/E
- -5.64
- Beta
- 1.06
- Short ratio
- 2.34
- Inst. own
- 6.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 10, 2025
- 50-d avg
- 2.38
- 200-d avg
- 2.99
- 1y target
- 10.00
Discussion (15)
Sign in to join the discussion
Chris LEXX 10 months ago #1Charles Schwab is only allowing buys if you contact a broker, this discourages buying, I don’t like it!!! I was going to buy a few thousand more but I’m not going to because it’s not easy.
Chris LEXX 10 months ago #2Ricardo Lexx does not pay dividends
Chris LEXX 1 year ago #3How come I just found out about this? How can LEXX be trading under a dollar currently ???? The deal (below) was inked in March of 2025 “ Novo Nordisk signed a $1 billion licensing deal with Lexicon Pharmaceuticals, granting it exclusive global rights to Lexicon's oral obesity drug candidate, LX9851. Separately, Lexaria Bioscience is working on oral formulations of other drugs but has not merged with Novo Nordisk”
VICKY HANUKA LEXX 3 years ago #4A Maxim Group analyst maintained a Buy rating on Lexaria Bioscience (NASDAQ: LEXX) with a price target of $2.00. Shares closed up 7% at $0.9.
Christian Willy Ramirez Benavides LEXX 5 years ago #5Consolidation, bears will come!!
Christian Willy Ramirez Benavides LEXX 5 years ago #6Another run for tomorrow
Christian Willy Ramirez Benavides LEXX 5 years ago #7Here we go
Christian Willy Ramirez Benavides LEXX 5 years ago #8Its coming guys
Christian Willy Ramirez Benavides LEXX 5 years ago #9Bring that 11 over here!!!
Christian Willy Ramirez Benavides LEXX 5 years ago #10Told u guys, keep buying